ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "radiography"

  • Abstract Number: 1116 • ACR Convergence 2021

    Disease Characteristics of Steroid-Induced Spinal Epidural Lipomatosis: A Systematic Review

    Haseeb Chaudhary1, Usama Nasir2, Khezar Syed3, Abigayle Sullivan3, Shilla Zachariah3, Christian AkemDimala3, Muhammad Khan4 and Anthony Donato3, 1Tower Health System, Reading, PA, 2Reading Hospital, Tower Health System, Reading, PA, 3Reading Hospital, Tower Health System, Reading, PA, 4University of Kentucky, Lexington, KY

    Background/Purpose: Steroid-induced epidural lipomatosis (SEL) is a rare phenomenon causing neuronal compression from adipose tissue deposition in the epidural space. We analyzed the available literature…
  • Abstract Number: 1210 • ACR Convergence 2021

    Frequency of Anterior Atlanto-Axial Subluxation in Patients with Rheumatoid Arthritis

    Joan Manuel Dapeña1, Eliana Serrano1, Silvana Perez1, Juan Manuel Bande1, Belen Barrios1, María Alejandra Medina1, Diana Klajn1, Jose Caracciolo1, Mariana Benegas2, Analía Dellepiane3, Julieta Silvana Morbiducci4, Maria Cecilia Castro4, Anastasia Secco4, Julia Sosa5, María Paula Kohan6, María Noelia Bersano7, Yamila Chichotky8, José Luis Velasco Zamora9, Víctor Leonardo Yohena10, Laura Rocca10, analia alvarez11, Karin Ingrid Kirmayr12, Galo Saltos Farinango13, Oscar Rillo14, María de los Ángeles Correa15, Analía Verónica Bohr16, Adriana Pérez Dávila17, Nicolas Perez18 and Silvia Papasidero1, 1Hospital General de Agudos Dr. Enrique Tornú, Buenos Aires, Argentina, 2Sanatorio Dr. Julio Méndez, Buenos Aires, Argentina, 3Centro de Especialidades Médicas Caseros, Casilda, Santa Fé, Casilda, Santa Fé, Argentina, 4Hospital General de Agudos Bernardino Rivadavia, Buenos Aires, Argentina, 5Hospital Municipal Dr. Raúl F. Larcade, San Miguel, Buenos Aires, Argentina, 6Hospital Municipal Dr. Raúl F. Larcade, San Miguel, Pilar, Argentina, 7Hospital Provincial de Rosario, Santa Fé, Argentina, 8Reumatología al Sur, Berazategui, Buenos Aires, Argentina, 9Reumatología al Sur, Berazategui, Berazategui, Argentina, 10Hospital General de Agudos Dr. José Penna, Buenos Aires, Buenos Aires, Argentina, 11Hospital General de Agudos Dr. José Penna, Buenos Aires, Argentina, 12Sanatorio San Carlos, Bariloche, Argentina, 13Hospital General de Agudos Dr. Ignacio Pirovano, Buenos Aires, Argentina, 14Hospital I. Pirovano, Buenos Aires, Argentina, 15Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, 16Hospital de Rehabilitación M. Rocca, Ciudad autónoma de Buenos Aires, Argentina, 17Hospital de Rehabilitación M. Rocca, Buenos Aires, Argentina, 18Instituto de Investigaciones Médicas Alfredo Lanari, Buenos Aires, Argentina

    Background/Purpose: According to some series, cervical spine is the second most affected region in Rheumatoid arthritis (RA). Cervical involvement was reported in 80% of RA…
  • Abstract Number: 2017 • ACR Convergence 2020

    Machine Learning Identifies an Association Between Pre-existing Radiographic Damage and Long-term Clinical Outcomes with Secukinumab Therapy in Patients with Psoriatic Arthritis

    Philip Mease1, Désirée van der Heijde2, Bruce Kirkham3, Georg Schett4, Ana-Maria Orbai5, Christopher Ritchlin6, Joseph Merola7, Luminita Pricop8, Xuan Zhu9, DavidA James9 and Gregory Ligozio9, 1Seattle Rheumatology Associates, P.L.L.C., Seattle, WA, 2Leiden University Medical Center, Leiden, Netherlands, 3Guy's & St Thomas' NHS Foundation Trust, London, United Kingdom, 4Friedrich-Alexander-Universität Erlangen- Nuremberg, Erlangen, Germany, 5Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, 6Department of Medicine, University of Rochester Medical Center, Rochester, NY, 7Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, 8Novartis Pharmaceuticals Corporation, East Hanover, 9Novartis Pharmaceuticals Corporation, East Hanover, NJ

    Background/Purpose: Assessment of radiographic joint damage extent and progression is important in clinical trials evaluating treatments for psoriatic arthritis (PsA). Joint damage in patients with…
  • Abstract Number: 0493 • ACR Convergence 2020

    Automatic Joint Space Assessment in Hand Radiographs with Deep Learning Among Patients with Rheumatoid Arthritis

    Yun-Ju Huang1, Chang-Fu Kuo1, Fakai Wang2, Shun Miao2, Kang Zheng2 and Le Lu2, 1Chang Gung Memorial Hospital, Taoyuan, Taiwan (Republic of China), 2PAII labs, Bethesda, MD

    Background/Purpose: Assessment of joint space is the fundamental radiographic task to diagnose rheumatoid arthritis (RA) and to assess the severity and progression of the disease.…
  • Abstract Number: 0727 • ACR Convergence 2020

    Hip Involvement Leads to Poor Outcome in Adulthood in Children with Enthesitis Related Arthritis (ERA) Category of Juvenile Idiopathic Arthritis (JIA)

    Naveen R1, Namita Mohindra1, Neeraj Jain1 and Amita Aggarwal2, 1Sanjay Gandhi Post graduate institute of medical sciences, Lucknow, Uttar Pradesh, India, 2Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India

    Background/Purpose: Enthesitis related arthritis (ERA) is the commonest category of JIA seen in India and constitutes 30-40% of all JIA patients. There are many studies…
  • Abstract Number: 0748 • ACR Convergence 2020

    Joint Space Narrowing Precedes Erosive Radiographic Damage in Patients with Rheumatoid Arthritis

    Andreas Kerschbaumer1, Gabriela Supp2, Farideh Alasti1, Josef Smolen2 and Daniel Aletaha1, 1Division of Rheumatology, Department of Medicine III, Medical University of Vienna,, Vienna, Austria, 2Division of Rheumatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria

    Background/Purpose: Rheumatoid arthritis (RA) is a chronic inflammatory disease characterized through symmetric polyarthritis leading to joint destruction over time in many patients. Radiographic damage is…
  • Abstract Number: 0754 • ACR Convergence 2020

    The Association Between Continuous Decreases in Serum RF Titers and Radiographic Remission of Joint Damage in RA Patients Treated with Biological or Targeted Synthetic DMARDs

    Takayoshi Owada1, Ayae Tanaka2, Hirokuni Hirata1, Masafumi Arima3, Yasutsugu Fukushima1 and Kazuhiro Kurasawa3, 1Dokkyo Medical University Saitama Medical Center, Koshigaya, Saitama, Japan, 2Dokkyo Medical University, Shimotsuga-Gun, Japan, 3Dokkyo Medical University, Mibu, Shimotsugagun, Tochigi, Japan

    Background/Purpose: Rheumatoid factors (RFs) are RA-related autoantibodies like anti-cyclic citrullinated peptide antibodies, and are used for classifying and diagnosing RA. In addition, positivity and high…
  • Abstract Number: 1049 • ACR Convergence 2020

    Effects of Nintedanib in Patients with Progressive Fibrosing Autoimmune Disease-related Interstitial Lung Diseases (ILDs) in the INBUILD Trial: Subgroups by HRCT Pattern

    Paul Dellaripa1, Martin Aringer2, Anna Maria Hoffmann-Vold3, Clive Kelly4, Shikha Mittoo5, Alexandra James6, Klaus Rohr6, Susanne Stowasser6 and Yoshikazu Inoue7, 1Division of Rheumatology, Brigham and Women's Hospital, Boston, Massachusetts, USA, Boston, MA, 2Rheumatology, Medicine III, University Medical Center & Faculty of Medicine, TU Dresden, Dresden, Germany, Dresden, Germany, 3Department of Rheumatology, Oslo University Hospital, Oslo, Norway, Oslo, Norway, 4Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK, Newcastle upon Tyne, United Kingdom, 5University Health Network, Toronto, Ontario, Canada, Toronto, ON, Canada, 6Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany, Ingelheim am Rhein, Germany, 7Clinical Research Center, National Hospital Organization Kinki-Chuo Chest Medical Center, Sakai City, Osaka, Japan, Sakai City, Osaka, Japan

    Background/Purpose: In the INBUILD trial, nintedanib reduced the rate of decline in forced vital capacity (FVC) over 52 weeks compared with placebo in patients with…
  • Abstract Number: 1161 • ACR Convergence 2020

    Perspectives of Radiologist Physicians in the Imaging of Chronic Nonbacterial Osteomyelitis

    Farzana Nuruzzaman1, Mingqian Huang2, Christian Hedrich3, Hermann Girschick4, Julie Cherian5, T. Shawn Sato6, Karen Onel7, Polly Ferguson8 and Yongdong Zhao9, 1Stony Brook Children's Hospital, Stony Brook, NY, 2Mount Sinai Hospital, 10003, NY, 3University of Liverpool, Liverpool, United Kingdom, 4Vivantes Children’s Hospital, Wuerzburg, Germany, 5Stony Brook Children�s Hospital, Stony Brook, NY, 6University of Iowa, Iowa City, 7Pediatric Rheumatology, Hospital for Special Surgery, New York, NY, 8University of Iowa Carver College of Medicine, Iowa City, IA, 9University of Washington, Seattle, WA

    Background/Purpose: Radiological imaging is integral to the diagnosis of chronic nonbacterial osteomyelitis (CNO) and has been included as a central component in suggested diagnostic criteria…
  • Abstract Number: 1235 • ACR Convergence 2020

    Radiographic Progression of Structural Joint Damage over 5 Years of Baricitinib Treatment in Patients with Rheumatoid Arthritis: Results from RA-BEYOND

    Désirée van der Heijde1, Cynthia E Kartman2, Li Xie2, Scott Beattie2, Douglas Schlichting2, Patrick Durez3, Yoshiya Tanaka4 and Roy Fleischmann5, 1Leiden University Medical Center, Leiden, Netherlands, 2Eli Lilly and Company, Indianapolis, IN, 3Division of Rheumatology, Cliniques Universitaires Saint-Luc, Bruxelles, Belgium, 4The First Department of Internal Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan, 5Southwestern Medical Center, Metroplex Clinical Research Center, Dallas, TX

    Background/Purpose: Baricitinib (BARI) is an oral, reversible and selective Janus kinase 1 and 2 inhibitor. Treatment with once-daily oral BARI resulted in low rates of…
  • Abstract Number: 1458 • ACR Convergence 2020

    Slower Current Walking Speed Is Associated with Progression in Radiographic Knee Osteoarthritis: The Johnston County Osteoarthritis Project

    Lindsey Duca1, Liubov Arbeeva2, Yvonne Golightly3, Louise Murphy4, Charles Helmick4 and Kamil Barbour5, 1Centers for Disease Control and Prevention, Chamblee, GA, 2University of North Carolina at Chapel Hill Thurston Arthritis Research Center, Chapel Hill, NC, 3University of North Carolina at Chapel Hill Dept of Epidemiology, Chapel Hill, NC, 4Centers for Disease Control and Prevention, Atlanta, GA, 5CDC, Atlanta, GA

    Background/Purpose: Poorer physical functioning as a single baseline measurement has been associated with increased risk of radiographic knee osteoarthritis (rKOA) progression, but it is unknown…
  • Abstract Number: 1487 • ACR Convergence 2020

    Biclustering Reveals Potential Knee Osteoarthritis Phenotypes in Exploratory Analyses: Data from the Osteoarthritis Initiative

    Amanda Nelson1, Thomas Keefe2, Todd Schwartz3, Richard Loeser1, Yvonne Golightly4, Liubov Arbeeva1 and J Marron2, 1University of North Carolina at Chapel Hill Thurston Arthritis Research Center, Chapel Hill, NC, 2University of North Carolina at Chapel Hill, Chapel Hill, NC, 3University of North Carolina at Chapel Hill Dept of Biostatistics, Chapel Hill, NC, 4University of North Carolina at Chapel Hill Dept of Epidemiology, Chapel Hill, NC

    Background/Purpose: To utilize novel methodologies to explore subgroups within the OAI clinical data.Methods: From the OAI baseline dataset (n=4796 individuals with or at risk of…
  • Abstract Number: 1644 • ACR Convergence 2020

    Radiographic Exclusionary Findings During Screening for Three Phase III Trials of Subcutaneous Tanezumab in Patients with Moderate to Severe Hip or Knee Osteoarthritis

    Ali Guermazi1, Frank Roemer2, Andrew Kompel1, Luis Diaz3, Michel Crema4, Mark Brown5, Anne Hickman5, Glenn Pixton6, Lars Viktrup7, Robert Fountaine5, Aimee Burr5, Sarah Sherlock5 and Christine West8, 1Boston University School of Medicine, Boston, MA, 2Boston University School of Medicine, Boston, MA, and Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany, Erlangen, Germany, 3Boston Veteran Affairs Healthcare System, Boston, MA, 4Boston University School of Medicine, Paris, France, 5Pfizer Inc., Groton, CT, 6Pfizer Inc., Morrisville, NC, 7Eli Lilly and Company, Indianapolis, IN, 8Pfizer Inc, Groton, CT

    Background/Purpose: Tanezumab is a nerve growth factor monoclonal antibody in development for osteoarthritis (OA). Following a clinical hold due to concerns around adverse joint events,…
  • Abstract Number: 1756 • ACR Convergence 2020

    Comparable Long-Term Outcomes Among DAS28-ESR-based Remission Criteria and ACR/EULAR Definitions in Patients with Established Rheumatoid Arthritis

    Felipe Julio Ramirez Garcia1, Jose Inciarte-Mundo2, Andrea Cuervo3, Raquel Celis4, Virginia Ruiz-Esquide4, Raul Castellanos-Moreira5, Andres Ponce4, Jose Gómez-Puerta6, Raimon Sanmartí6 and Juan Cañete7, 1Arthritis Unit, Rheumatology Dpt, Hospital Clinic, Barcelona, Spain, Barcelona, Catalonia, Spain, 2Hospital Universitari Clínic de Barcelona, Barcelona, 3Hospital Clínic, Barcelona, Spain, 4Hospital Clinic, Barcelona, Spain, 5Hospital Clinic of Barcelona, Barcelona, Spain, 6Hospital Universitari Clínic de Barcelona, Barcelona, Catalonia, Spain, 7Arthritis Unit, Rheumatology Dpt, Hospital Clinic, Barcelona, Spain and IDIBAPS, Barcelona, Spain

    Background/Purpose: To compare long-term clinical and radiographic outcomes among five sets of remission criteria [four clinical and one Ultrasound (US)-based] in a cohort of RA…
  • Abstract Number: 1895 • ACR Convergence 2020

    Radiographic Progression in Patients with Axial Spondyloarthritis Under Treatment with TNF Inhibitors. Data from REGISPONSERBIO (Spanish Register of Biological Therapy in Spondyloarthritides)

    Maria Llop1, Mireia Moreno2, Jordi Gratacós3, Victoria Navarro-Compán4, Eugenio De Miguel5, Pilar Font6, Teresa Clavaguera7, Luis Francisco Linares8, Beatriz Joven9 and Xavier Juanola10, 1Hospital Universitari Parc Taulí I3PT, Sabadell, Catalonia, Spain, 2Hospital Universitari Parc Taulí I3PT, Sabadell, Spain, 3University Hospital Parc Tauli Sabadell, Barcelona, Spain, 4Hospital Universitario La Paz IdiPaz, Madrid, Pais Vasco, Spain, 5Rheumatology Department, Hospital Universitario La Paz, Madrid, Spain, 6Rheumatology Department, Reina Sofia University Hospital/ Maimonides Institute for Research in Biomedicine of Cordoba (IMIBIC)/ University of Cordoba, Cordoba, Spain, Córdoba, Spain, 7Hospital Universitari Trueta, Girona, Spain, 8Hospital de la Arrixaca, Murcia, 9Hospital Universitario 12 de Octubre, Madrid, Spain, 10Rheumatology Service, University Hospital Bellvitge, IDIBELL, Barcelona, Spain, Barcelona, Spain

    Background/Purpose: Clinical efficacy of TNF inhibitors (TNFi) in axial spondyloarthritis (axSpA) has been widely probed in randomized control trials. In clinical practice, some studies suggested…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 9
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology